4527
Rohto Pharmaceutical Co., Ltd.
2026/01/07
Rohto Pharmaceutical plans to acquire 790,600 shares, equivalent to 51% of voting rights, of Thai wellness company Thann Oryza Co., Ltd., making it a subsidiary. The share transfer is scheduled for March 31, 2026.
